Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/1924
Title: | Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines | Authors: | Nourse, C. Osowicki, J. Palasanthiran, P. Starr, M. Lai, T. Francis, J. R. Bryant, P. A. Isaacs, D. McMullan, B. J. Andresen, D. Blyth, C. C. Avent, M. L. Bowen, A. C. Britton, P. N. Clark, J. E. Cooper, C. M. Curtis, N. Goeman, E. Hazelton, B. Haeusler, G. M. Khatami, A. Newcombe, J. P. |
Issue Date: | 2016 | Source: | 16, (8), 2016, p. e139-e152 | Pages: | e139-e152 | Journal: | The Lancet Infectious Diseases | Abstract: | Few studies are available to inform duration of intravenous antibiotics for children and when it is safe and appropriate to switch to oral antibiotics. We have systematically reviewed antibiotic duration and timing of intravenous to oral switch for 36 paediatric infectious diseases and developed evidence-graded recommendations on the basis of the review, guidelines, and expert consensus. We searched databases and obtained information from references identified and relevant guidelines. All eligible studies were assessed for quality. 4090 articles were identified and 170 studies were included. Evidence relating antibiotic duration to outcomes in children for some infections was supported by meta-analyses or randomised controlled trials; in other infections data were from retrospective series only. Criteria for intravenous to oral switch commonly included defervescence and clinical improvement with or without improvement in laboratory markers. Evidence suggests that intravenous to oral switch can occur earlier than previously recommended for some infections. We have synthesised recommendations for antibiotic duration and intravenous to oral switch to support clinical decision making and prospective research.L6126156282016-10-14 | DOI: | 10.1016/S1473-3099(16)30024-X | Resources: | https://www.embase.com/search/results?subaction=viewrecord&id=L612615628&from=exporthttp://dx.doi.org/10.1016/S1473-3099(16)30024-X | | Keywords: | central nervous system infection;childhood disease;endocarditis;human;musculoskeletal infection;pelvic inflammatory disease;priority journal;respiratory tract infection;review;skin infection;soft tissue infection;systematic review;treatment outcome;urogenital tract infection;bacteremia;antibiotic therapy;abdominopelvic infection;antibiotic agentabdominal infection;bacterial infection | Type: | Article |
Appears in Sites: | Children's Health Queensland Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.